Market research
SPEC.LSE Inspecs Group plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 105M
- P/E ratio
- Not available
- Analyst target
- 60.0298
- Dividend yield
- Not available
- Beta
- 1.6
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- GB00BK6JPP03
- Market cap
- 105M
- P/E ratio
- Not available
- Analyst target
- 60.0298
- Dividend yield
- Not available
- Beta
- 1.6
About
About Inspecs Group plc
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics product distribution and Manufacturing segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri-Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O'Polo, MINI, O'Neill, RADLEY, Superdry & Co, TALBOT RUNHOF, Ted Baker, and VIKTOR & ROLF and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY'S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SPEC.LSE discussion.
5 years, 4 months ago
Inspecs Group plc is currently in a long term uptrend where the price is trading 23.7% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.2.
Based on the above factors, Inspecs Group plc gets an overall score of 2/5.